Sagimet Biosciences grants 63,600 stock options to two new employees
Bitget2026/10/29 11:08- Sagimet Biosciences granted 63,600 stock options to two newly hired employees on Oct. 28, 2026.
- The options cover Series A common stock, have a 10-year term and vest over four years.
- Vesting begins with 25% on the first anniversary of each employee's employment-based vesting commencement date.
- The remaining shares vest monthly over 36 months, subject to continued service through each vesting date.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish
CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.
JPMorgan raises target prices for Target and Walmart
Orient Precision Industries Holds Extraordinary Shareholders Meeting
Citi optimistic about international oil companies: low-cost resource reserves being rebuilt may drive energy sector to reverse a decade-long valuation discount
With oil prices in the mid-$70s range, Citi believes that global international oil companies (IOCs) can deliver a free cash flow yield of 7% to 8%, and achieve a real growth rate of 4% to 5% over a period of time.
Crypto prices
More
